Champions Oncology (CSBR) Posts Narrower Q1 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $4.81 --0%
Financial Fact:
Cost of translational oncology solutions: 2.05M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Financial Fact:
Cost of translational oncology solutions: 2.05M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q1 EPS of ($0.15), versus ($0.24) reported last year. Revenue for the quarter came in at $3.7 million, versus $2.8 million reported last year.
Reaffirms FY17 outlook.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Lear Corp. (LEA) Tops Q3 EPS by 39c ; Offers Guidance
- Federal Realty Inv. Trust (FRT) Tops Q3 EPS by 3c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
